Corps Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Corps Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Sell	1,949 -957	-33%	-$459K	0.79%	33
2026 Q1	$1.43M	Sell	2,906 -150	-5%	-$81.4K	1.24%	24
2025 Q4	$1.77M	Buy	3,056 +886	+41%	+$501K	1.83%	17
2025 Q3	$1.05M	Sell	2,170 -15	-0.7%	-$6.98K	1.59%	19
2025 Q2	$886K	Buy	2,185 +14	+0.6%	+$5.85K	1.42%	22
2025 Q1	$1.08M	Sell	2,171 -35	-2%	-$19K	1.14%	31
2024 Q4	$1.15M	Buy	+2,206	New	+$1.21M	1.16%	30

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Corps Capital Advisors's TMO Position: Q2 2026 in Review

Corps Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 33% in Q2 2026, selling an estimated $459K and leaving 1,949 shares worth $977K. The position accounts for 0.79% of the portfolio, ranked #33.

Corps Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.77M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Corps Capital Advisors held 1,949 shares of Thermo Fisher Scientific worth $977K as of Q2 2026.
Corps Capital Advisors sold 957 Thermo Fisher Scientific shares in Q2 2026, an estimated $459K.
Thermo Fisher Scientific made up 0.79% of Corps Capital Advisors's portfolio in Q2 2026, its #33 holding.
Corps Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Corps Capital Advisors's Thermo Fisher Scientific position peaked at $1.77M in Q4 2025.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Corps Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.